CHAMP: The Childhood and Adolescent Migraine Prevention Study

To evaluate if amitriptyline (AMI) and topiramate (TPM) are superior to placebo in reducing migraine frequency in children and adolescents, ages 8 to 17 years old, inclusive, and to conduct a comparative effectiveness study of the two therapies.

Principal Investigator

CONTACT INFORMATION

Primary Contact:
Maria Coburn
(650) 736-9551